FOCINVEZ (FOSAPREPITANT DIMEGLUMINE)
FOCINVEZ (FOSAPREPITANT DIMEGLUMINE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: FOCINVEZ; Generic name: FOSAPREPITANT DIMEGLUMINE; Manufacturer: Steriscience Specialties Private Limited.
| Brand name | FOCINVEZ |
|---|---|
| Generic name | FOSAPREPITANT DIMEGLUMINE |
| Manufacturer | Steriscience Specialties Private Limited |
| Used for | 1 INDICATIONS AND USAGE FOCINVEZ, in combination with other antiemetic agents, is indicated in adults and pediatric patients 6 months of age and older for the prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). Limitations of Use FOCINVEZ has not been studied for the treatment of established nausea and vomiting. FOCINVEZ is a substance P/neurokinin-1 (NK 1 ) receptor antagonist, indicated in adults and pediatric patients 6 months of age and older, in |
| Dosage | 2 DOSAGE AND ADMINISTRATION Recommended Adult Dosage ( 2.1 ) FOCINVEZ 150 mg on Day 1 as an intravenous infusion over 20 to 30 minutes; Complete the infusion approximately 30 minutes prior to chemotherapy. Recommended Dosage for Pediatric Patients (6 months to 17 years) Weighing at Least 6 kg ( 2.2 ) See Full Prescribing Information for pediatric dosage regimens by age. single dose chemotherapy regimens: single dose of FOCINVEZ on Day 1. single or multi-day chemotherapy regimens: 3-day regimen o |
| Active ingredient(s) | FOSAPREPITANT DIMEGLUMINE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18a60093-cec8-1b8c-e063-6394a90a8902 |